The recent Danish study of 2,320 women between the ages of 35 and 79 (including 756 with ovarian cancer of varying severity) found that women who took aspirin two or more times per week for longer than a month were less likely to develop ovarian cancer than those who typically took non-aspirin pain relievers, or none at all.